false
Catalog
The Lead Episode 7: A Discussion of Safety and Eff ...
The Lead Episode 7 Speaker Information
The Lead Episode 7 Speaker Information
Back to course
Pdf Summary
The article "Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry" discusses the findings from a registry that examines the safety and effectiveness of pulsed field ablation (PFA) in treating atrial fibrillation (AF). PFA is a novel catheter-based technology that uses pulsed electric fields to create lesions in the heart tissue to disrupt abnormal electrical signals that cause AF.<br /><br />The registry included data from 249 patients who underwent PFA for AF at multiple centers across Europe. The primary endpoint of the study was the incidence of major adverse events (MAEs) within one year of the procedure. MAEs included any complications related to the PFA procedure such as stroke, heart attack, or death.<br /><br />The results showed that the incidence of MAEs was low, with only 3.2% of patients experiencing a MAE within one year. The most common complications were related to access site complications and cardiac tamponade, which is the accumulation of fluid around the heart. These complications were manageable with standard interventions.<br /><br />In terms of effectiveness, the study found that 61.6% of patients were free from AF recurrence without the need for antiarrhythmic medications at one year. This suggests that PFA may be a promising treatment option for patients with AF.<br /><br />The authors note that further studies are needed to compare PFA with other ablation technologies and to evaluate long-term outcomes. They also highlight the need for standardized protocols and training to ensure safe and effective implementation of PFA.<br /><br />Overall, the study provides valuable insights into the safety and effectiveness of PFA in treating AF. It adds to the growing body of evidence supporting the use of PFA as an alternative to traditional ablation techniques for patients with AF.
Keywords
Pulsed Field Ablation
Atrial Fibrillation
MANIFEST-PF Registry
Catheter-based technology
Abnormal electrical signals
Major adverse events
Access site complications
Cardiac tamponade
Antiarrhythmic medications
Long-term outcomes
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English